Comparative Pharmacology
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 9 versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DEXTROSE 5 AND SODIUM CHLORIDE 0 9 versus MAGNESIUM SULFATE IN DEXTROSE 5 IN PLASTIC CONTAINER.
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% vs MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Dextrose 5% provides a source of calories and fluid for hydration, preventing ketosis by providing a minimal carbohydrate source. Sodium chloride 0.9% supplies electrolytes and maintains osmotic pressure in extracellular fluid.
Magnesium sulfate provides magnesium ions, which are essential for various physiological processes. It acts as a cofactor for enzymatic reactions, stabilizes excitable membranes, and antagonizes calcium entry at the neuromuscular junction, leading to reduced acetylcholine release and muscle relaxation. In the CNS, it may act as a noncompetitive antagonist of NMDA receptors, exerting anticonvulsant effects.
Intravenous infusion; typical adult dose is 500-1000 mL as a single dose, administered at a rate determined by clinical condition (e.g., 100-200 mL/h for maintenance).
1 to 4 g intravenously as a 5% to 20% solution, rate not exceeding 150 mg/min; dosing frequency depends on indication (e.g., preeclampsia/eclampsia: 4-5 g IV loading then 1-2 g/hr infusion; hypomagnesemia: 1-2 g IV over 1-2 hours, may repeat based on serum magnesium levels).
None Documented
None Documented
Glucose has a plasma half-life of approximately 1.5-2.5 hours in normal individuals, reflecting rapid cellular uptake and metabolism. Sodium and chloride have no definable half-life as they are actively regulated; however, the half-life of infused sodium is approximately 2-4 hours depending on renal function.
Terminal half-life approximately 4-5 hours in normal renal function; prolonged in renal impairment (up to 40 hours).
Glucose is completely metabolized to CO2 and water; renal excretion of unchanged glucose is negligible (<1%) in normoglycemic patients. Sodium and chloride are primarily excreted renally (90-95% of infused load) with small fecal and sweat losses. In dextrose 5% and sodium chloride 0.9%, both components are eliminated renally; the dextrose is metabolized, not excreted unchanged.
Primarily renal (90-100% as unchanged magnesium). Less than 1% biliary/fecal.
Category A/B
Category C
Electrolyte
Electrolyte